Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial (Q43078724)
Jump to navigation
Jump to search
scientific article published in May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial |
scientific article published in May 2010 |
Statements
1 reference
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial (English)
1 reference
Karen S Pieper
1 reference
Robert M Califf
1 reference
Kenneth W Mahaffey
1 reference
Elliott M Antman
1 reference
Neal S Kleiman
1 reference
Harvey D White
1 reference
SYNERGY Trial Investigators
1 reference
Philip E Aylward
1 reference
Marc Cohen
1 reference
Glenn N Levine
1 reference
Lan Lan
1 reference
1 May 2010
1 reference
1 reference
75
1 reference
6
1 reference
928-935
1 reference
Identifiers
1 reference
1 reference